|Articles|November 15, 2002

HRT in Trouble

San Francisco - Despite the unexpected finding that combined use of oral conjugated equine estrogens (CEE) and oral medroxyprogesterone acetate (MPA) actually raises a healthy menopausal women's risk of coronary heart disease, and that it increases invasive breast cancer risk, gynecologist Susan Ballagh, M.D., remains a proponent of the popular regimen for appropriate patients.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME